Skip to search formSkip to main contentSkip to account menu

avanafil

Known as: (S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide, 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide 
An orally available phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Avanafil selectively inhibits PDE5, thus inhibiting the… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Pyrimidines

Narrower (1)

TA-1790
avanafil 200 MG Oral Tablet [Stendra]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
ANGIOEDEMA AFTER SILDENAF/ ANGIOEDEMA AFTER SILDENAFIL EXPOSURE
2015
2015
DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF AVANAFIL AND DAPOXETINE HCl IN TABLET DOSAGE FORM
A simple, economic, selective, precise, accurate and sensitive HPTLC method for analysis of Avanafil and Dapoxetine HCl, as a… 
Review
2014
Review
2014
Avanafil for the treatment of erectile dysfunction. An updated review.
OBJECTIVES Avanafil is a highly selective phosfosdiesterase 5 inhibitor (PDE5 inhibitor), with rapid onset of action, approved by… 
2014
2014
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AVANAFIL AND DAPOXENTINE HYDROCHLORIDE IN BULK AND DOSAGE FORM
To develop and validate a simple, economical, sensitive and accurate Chromatographic (RP-HPLC) Method for simultaneous estimation… 
Review
2012
Review
2012
Looking to the Future for Erectile Dysfunction Therapies
The treatment of erectile dysfunction (ED) has been revolutionized during the last 2 decades with several treatment options now… 
Review
2012
Review
2012
Efficacy and satisfaction rates of oral PDE5is in the treatment of erectile dysfunction secondary to spinal cord injury: A review of literature
Abstract Concept Decreased sexual function is a major concern of men with spinal cord injuries (SCIs). Treatment of erectile… 
2006
2006
923: Safety and Efficacy of Avanafil, A New Phosphodiesterase Type-5 (PDE-5) Inhibitor for Treating Erectile Dysfunction
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the… 
2006
2006
HAEMODYNAMIC EFFECTS OF CO-ADMINISTRATION OF AVANAFIL AND GLYCERYL TRINITRATE
2006
2006
SAFETY AND EFFICACY OF AVANAFIL, A NEW PDE5 INHIBITOR FOR TREATING ERECTILE DYSFUNCTION
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)